BEAM (STOCKS)
Beam Therapeutics Inc. Common Stock
$26.000000
-0.950000 (-3.53%)
Prev close: $26.950000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- John Evans
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,681.13M
- Employees
- 510
- P/E (TTM)
- -5.86
- P/B (TTM)
- 2.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $55.70M |
| Benefits Costs and Expenses | $470.34M |
| Costs And Expenses | $470.34M |
| Nonoperating Income/Loss | $51.64M |
| Operating Expenses | $521.99M |
| Depreciation and Amortization | $22.07M |
| Research and Development | $411.79M |
| Other Operating Expenses | $88.13M |
| Operating Income/Loss | -$466.29M |
| Income/Loss From Continuing Operations After Tax | -$414.64M |
| Income/Loss From Continuing Operations Before Tax | -$414.64M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$414.64M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$414.64M |
| Net Income/Loss Available To Common Stockholders, Basic | -$414.64M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.42 |
| Diluted Earnings Per Share | -$4.42 |
| Basic Average Shares | 197,766,403 |
| Diluted Average Shares | 197,766,403 |
| Assets | $1.31B |
| Current Assets | $1.10B |
| Cash | $1.10B |
| Noncurrent Assets | $212.53M |
| Fixed Assets | $108.29M |
| Other Non-current Assets | $104.24M |
| Liabilities | $345.08M |
| Current Liabilities | $182.56M |
| Accounts Payable | $9.55M |
| Wages | $16.50M |
| Other Current Liabilities | $156.51M |
| Noncurrent Liabilities | $162.52M |
| Equity | $966.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $966.00M |
| Liabilities And Equity | $1.31B |
| Net Cash Flow From Operating Activities | -$338.18M |
| Net Cash Flow From Operating Activities, Continuing | -$338.18M |
| Net Cash Flow From Investing Activities | -$103.57M |
| Net Cash Flow From Investing Activities, Continuing | -$103.57M |
| Net Cash Flow From Financing Activities | $479.61M |
| Net Cash Flow From Financing Activities, Continuing | $479.61M |
| Net Cash Flow | $37.86M |
| Net Cash Flow, Continuing | $37.86M |
| Comprehensive Income/Loss | -$415.61M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$415.61M |
| Other Comprehensive Income/Loss | -$969.00K |
| Other Comprehensive Income/Loss Attributable To Parent | -$969.00K |